Literature DB >> 33273247

CORR Insights®: Do Cohabitants Reliably Complete Questionnaires for Patients in a Terminal Cancer Stage When Assessing Quality of Life, Pain, Depression, and Anxiety?

Joel L Mayerson1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33273247      PMCID： PMC8083927          DOI： 10.1097/CORR.0000000000001593

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.755


× No keyword cloud information.
  4 in total

1.  Family Caregivers' Subjective Caregiving Burden, Quality of Life, and Depressive Symptoms Are Associated With Terminally Ill Cancer Patients' Distinct Patterns of Conjoint Symptom Distress and Functional Impairment in Their Last Six Months of Life.

Authors:  Fur-Hsing Wen; Jen-Shi Chen; Wen-Chi Chou; Wen-Cheng Chang; Wen Chi Shen; Chia-Hsun Hsieh; Siew Tzuh Tang
Journal:  J Pain Symptom Manage       Date:  2018-09-27       Impact factor: 3.612

2.  Defining the Elements of Early Palliative Care That Are Associated With Patient-Reported Outcomes and the Delivery of End-of-Life Care.

Authors:  Michael Hoerger; Joseph A Greer; Vicki A Jackson; Elyse R Park; William F Pirl; Areej El-Jawahri; Emily R Gallagher; Teresa Hagan; Juliet Jacobsen; Laura M Perry; Jennifer S Temel
Journal:  J Clin Oncol       Date:  2018-02-23       Impact factor: 44.544

3.  Do Cohabitants Reliably Complete Questionnaires for Patients in a Terminal Cancer Stage when Assessing Quality of Life, Pain, Depression, and Anxiety?

Authors:  Olivier Q Groot; Nuno Rui Paulino Pereira; Michiel E R Bongers; Paul T Ogink; Erik T Newman; Jorrit-Jan Verlaan; Kevin A Raskin; Santiago A Lozano-Calderon; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2021-04-01       Impact factor: 4.176

4.  Medical Care Costs Associated with Cancer Survivorship in the United States.

Authors:  Angela B Mariotto; Lindsey Enewold; Jingxuan Zhao; Christopher A Zeruto; K Robin Yabroff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-06-10       Impact factor: 4.090
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.